Gene · 2237
Papers3,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exponential strand displacement amplification-assisted microchip electrophoresis for rapid and simultaneous detection of base excision repair enzymes. | J Chromatogr A | 2026 | 42815109 | PubTator, text mining | PubMed |
| Dual-Driver Myeloproliferative Neoplasm: Concurrent p190 BCR::ABL1 CML and JAK2 V617F Mutation: A Case Report and Literature Review. | Case Rep Hematol | 2026 | 42781115 | PubTator, text mining | PubMed |
| Integrated Genetic Screening Identifies FEN1 as a Selective Vulnerability and Temozolomide Resistance Mediator in Glioblastoma Stem Cells. | Cancer Res Commun | 2026 | 42770249 | PubTator, text mining | PubMed |
| Increased NETosis in Patients With Heart Failure Is Associated With Macrophage Activation Towards a Proinflammatory Phenotype. | J Cell Mol Med | 2026 | 42725813 | PubTator, text mining | PubMed |
| In vitro reconstitution of chromatin replication recapitulates symmetric histone recycling. | Nat Commun | 2026 | 42711322 | PubTator, text mining | PubMed |
| Low-Potential Electrochemiluminescence of Carbon Dots Enabled by Co-Mn Bimetallic Atoms for Bioanalysis. | Anal Chem | 2026 | 42689601 | PubTator, text mining | PubMed |
| Mitochondria-Targeted Multimodal Nanotherapeutics Suppress Oxidized mtDNA-Driven Inflammation at the Source. | Adv Sci (Weinh) | 2026 | 42681754 | PubTator, text mining | PubMed |
| DNA damage response genes in lung cancer: Diagnostic, prognostic, and therapeutic implications - A narrative review. | Crit Rev Oncol Hematol | 2026 | 42603641 | PubTator, text mining | PubMed |
| A systems biology approach to find representative genes in Acute Myeloid Leukemia. | PLoS One | 2026 | 42507679 | PubTator, text mining | PubMed |
| Intranasal drop of multiplex RNA therapy for SARS-CoV-2 infections: baicalein-enhanced FEN1 nuclease cleaving as a virus buster. | Emerg Microbes Infect | 2026 | 42504705 | PubTator, text mining | PubMed |
| Decoding dry eye disease based on bioinformatics and in vitro experimental: the role of immune responses and natural product intervention. | Hum Genomics | 2026 | 42471730 | PubTator, text mining | PubMed |
| Genetic variations in the base excision repair pathway and susceptibility to Wilms tumor in eastern Chinese children: a six-center case-control study. | Gene | 2026 | 42462820 | PubTator, text mining | PubMed |
| Signal logic gate mediated by a controllable CRISPR/Cas12a system for simultaneous detection of DNA mutation and methylation. | Anal Methods | 2026 | 42459132 | PubTator, text mining | PubMed |
| Ubiquitin-dependent degradation of p27Kip1 and p21Waf1/Cip1 by AMBRA1 ensures G1 and S phase progression and limits replication stress. | Nucleic Acids Res | 2026 | 42339621 | PubTator, text mining | PubMed |
| FEN1-Gated Rolling Circle Amplification Achieves Single-Base Mismatch Discrimination for Breast Cancer Biomarker Analysis. | Anal Chem | 2026 | 42310499 | PubTator, text mining | PubMed |
| FANCA-dependent FEN1 recruitment suppresses transcription-replication conflicts and PARPi sensitivity. | Mol Cell | 2026 | 42302790 | PubTator, text mining | PubMed |
| Single-Nucleotide Polymorphisms in Genes Associated with Mitochondrial and DNA Damage Response Modulate the Risk of Non-Alcoholic Fatty Liver Disease in Humans. | Int J Mol Sci | 2026 | 42278383 | PubTator, text mining | PubMed |
| Functional roles for FEN1 phosphate steering residues in multi-step substrate verification prior to reaction. | J Biol Chem | 2026 | 42248453 | PubTator, text mining | PubMed |
| Computational Analysis of Differentially Expressed Genes in Arsenic-Induced Carcinogenesis and Their Effect on Human Repair Mechanisms. | Environ Mol Mutagen | 2026 | 42219787 | PubTator, text mining | PubMed |
| XPF mediates 3' flap processing for FEN1-independent Okazaki fragment maturation. | Nucleic Acids Res | 2026 | 42186816 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2237/papers